Trials / Withdrawn
WithdrawnNCT04635826
The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
We propose to evaluate the interaction between expectations of receiving stimulants, neurophysiological activity and enhancement of cognitive performance using fMRI.
Detailed description
Participants will then be randomized in a balanced placebo design (BPD) crossing medication (10 mg of mixed amphetamine salts vs placebo) and expectancy (told active medication vs placebo medication), resulting in 4 different conditions 1) mixed amphetamine salts/told stimulant medication; 2) placebo/told stimulant medication; 3) mixed amphetamine salts/told placebo; and 4) placebo/told placebo). Participants will be assigned to four scanning sessions scheduled one week apart and will experience each condition once counterbalanced across participants. Participants will be administered cognitive tasks in and out of the scanner to determine the effects of medication vs expectancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adderall 10Mg Tablet | Participants will be administered Adderall |
| DRUG | Placebo | Participants will be administered placebo |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2029-07-31
- Completion
- 2030-07-31
- First posted
- 2020-11-19
- Last updated
- 2025-04-07
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04635826. Inclusion in this directory is not an endorsement.